Back

Employing epi-drugs to rescue lung microenvironmental changes in heart failure with preserved ejection fraction

20 January 2025 (15:00 - 14:00)
Organised by: Logo
Seminar Presentation Part of: Young Investigator Award Poster Session Hypertension, Pulmonary Hypertension Delegate Premium access HFA Winter Research Meeting on Translational Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Marialucia Telesca

Center for Translational and Experimental Cardiology (CTEC), Zurich (Switzerland)

11 More presentations in this session

Presentation thumbnail
Unveiling doxorubicin-induced cardiotoxicity: into the heart with single-cell resolution
Mr M. Mergiotti (Turin, IT)
Abstract Slides
Presentation thumbnail
Molecular insight by snRNA sequencing into early changes after intravenous immunoglobulin therapy leading to improved long-term outcome in dilated cardiomyopathy
Doctor F. Peisker (Maastricht, NL)
Abstract
Presentation thumbnail
Cell-type specific senolytic effects differentially influence cardiac responses to induced senescence
Doctor E. Lazzarini (Lugano, CH)
Abstract Slides
Presentation thumbnail
Exploring the metabolic adaptations in doxorubicin-induced cardiotoxicity
Doctor G. Guerra (Turin, IT)
Abstract Slides
Presentation thumbnail
NCOR1 regulates macrophage-driven inflammation in heart failure with preserved ejection fraction via the NLRP3-IL1b pathway: a translational study
Doctor E. Gorica (Zurich, CH)
Abstract Slides

Access the full session

Session thumbnail
Young Investigator Award Poster Session

The Event

Event poster

HFA Winter Research Meeting on Translational Heart Failure 2025

20 January - 22 January 2025

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources